Trial no.:
|
PACTR201508001241218 |
Date of Registration:
|
17/08/2015 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
botulinum in childhood strabismus |
Official scientific title |
Botulinum Neurotoxin as first line therapy in the management of Childhood esotropia |
Brief summary describing the background
and objectives of the trial
|
Esotropia is the most common type of strabismus in childhood. While accommodative esotropia is the most common type in industrial countries, infantile esotropis is the commonest type seen in our population. Early treatment of infantile esotropia has been shown to be associated with a greater chance of developing depth perception.
Surgery is the standard of treatment for infantile esotropia.In resource limited centers strabismus surgery is often relegated in preference to other more sight saving procedures. This results in a long delays in correcting strabismus in childhood. Botulinum neurotoxin injections have been used as an alternative therapy in the management of childhood esotropia.It is a quicker procedure with few complications. Many more patients can be treated in a given time when compared to surgery although repeat injections may be needed.In reported studies the success of surgery ranges from 60-80%, while the success of botulinum neurotoxin ranges from 42-60%.
The primary objective of the study is to compare outcomes in patients with concomitant esotropia receiving Botulinum injections to those undergoing standard surgical care.
Secondary objectives are to establish a. if the response to botulinum neurotoxin is influenced by the age at which the injection is first given.b. to establish if the baseline angle of strabismus will influence the response to the injection.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
childhood strabismus,Eye Diseases,Paediatrics,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
02/02/2015 |
Actual trial start date |
06/02/2015 |
Anticipated date of last follow up |
31/03/2017 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
250 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|